Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M55,128Revenue $M2,820Net Margin (%)11.7Altman Z-Score29.4
Enterprise Value $M54,858EPS $3.1Operating Margin %30.6Piotroski F-Score4
P/E(ttm)170Beneish M-Score-2.5Pre-tax Margin (%)28.6Higher ROA y-yN
Price/Book18.610-y EBITDA Growth Rate %--Quick Ratio4.1Cash flow > EarningsY
Price/Sales20.05-y EBITDA Growth Rate %--Current Ratio4.3Lower Leverage y-yY
Price/Free Cash Flow277y-y EBITDA Growth Rate %9.3ROA % (ttm)9.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)14.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M103ROIC % (ttm)17.5Gross Margin Increase y-yN

Gurus Latest Trades with REGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
REGNKen Fisher 2015-06-30 Add$438.27 - $539.4
($487.44)
$ 556.3014%Add 5.81%565
REGNKen Fisher 2015-03-31 Add$396.89 - $488.87
($423.8)
$ 556.3031%Add 1.91%534
REGNVanguard Health Care Fund 2014-12-31 Add0.12%$328.07 - $434.95
($393.59)
$ 556.3041%Add 4.49%2,921,000
REGNJoel Greenblatt 2014-12-31 Sold Out -0.01%$328.07 - $434.95
($394.04)
$ 556.3041%Sold Out0
REGNJoel Greenblatt 2014-09-30 Add$296.41 - $364.41
($335.27)
$ 556.3066%Add 60.05%1,410
REGNKen Fisher 2014-09-30 Buy $296.41 - $364.41
($335.27)
$ 556.3066%New holding583
REGNVanguard Health Care Fund 2014-06-30 Add0.79%$277.29 - $313.74
($296.6)
$ 556.3088%Add 60.34%2,795,500
REGNJoel Greenblatt 2014-06-30 Buy $277.29 - $313.74
($296.6)
$ 556.3088%New holding881
REGNMario Gabelli 2014-06-30 Buy $277.29 - $313.74
($296.6)
$ 556.3088%New holding2,295
REGNVanguard Health Care Fund 2014-03-31 Add0.29%$267.62 - $347.62
($306.26)
$ 556.3082%Add 23.47%1,743,468
REGNRon Baron 2014-03-31 Buy 0.01%$267.62 - $347.62
($307.2)
$ 556.3081%New holding6,084
REGNJoel Greenblatt 2013-12-31 Sold Out -0.03%$261.88 - $313.67
($287.35)
$ 556.3094%Sold Out0
REGNJoel Greenblatt 2013-09-30 Buy 0.03%$227.65 - $309.174
($262.76)
$ 556.30112%New holding3,285
REGNVanguard Health Care Fund 2013-03-31 Add0.62%$158.42 - $183.77
($171.66)
$ 556.30224%Add 170.41%1,412,100
REGNVanguard Health Care Fund 2012-09-30 Reduce-0.09%$112.77 - $152.66
($135.2)
$ 556.30311%Reduce 24.56%522,200
REGNDodge & Cox 2012-03-31 Sold Out $57.83 - $119.96
($92.23)
$ 556.30503%Sold Out0
REGNCarl Icahn 2011-09-30 Sold Out -1.76%$44.96 - $72.19
($58.66)
$ 556.30848%Sold Out0
REGNDodge & Cox 2011-09-30 Reduce-0.03%$44.96 - $72.19
($58.66)
$ 556.30848%Reduce 97.62%9,400
REGNVanguard Health Care Fund 2011-09-30 Add0.03%$44.96 - $72.19
($58.22)
$ 556.30856%Add 15.37%692,200
REGNDodge & Cox 2011-03-31 Buy 0.02%$32.61 - $44.68
($36.41)
$ 556.301428%New holding375,685
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

REGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


REGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GOLDSTEIN JOSEPH LDirector 2015-07-15Sell2,000$550-1.29view
GOLDSTEIN JOSEPH LDirector 2015-06-22Sell2,000$526.853.04view
SING GEORGE LDirector 2015-05-27Sell5,000$5155.41view
INGRAM ROBERT ALEXANDERDirector 2015-05-27Sell1,379$513.395.74view
Van Plew Daniel PSVP & General Mgr Industrial O 2015-05-26Sell18,370$508.426.78view
McCorkle Douglas SVP Controller and Asst Treasur 2015-05-22Sell13,000$515.65.29view
GOLDSTEIN JOSEPH LDirector 2015-05-22Sell4,000$514.285.56view
BROWN MICHAEL SDirector 2015-05-15Sell5,000$4959.67view
BAKER CHARLES ADirector 2015-03-25Sell5,000$454.9619.32view
Aberman Michael SSVP Strategy Investor Relation 2015-03-24Sell4,843$478.9913.34view

Quarterly/Annual Reports about REGN:

News about REGN:

Articles On GuruFocus.com
Brean Capital Weighs in on Medivation Following Update on TERRAIN Study Mar 26 2015 
1 Feb 23 2015 
1 Feb 23 2015 
Can These Three BioTech Companies Make It Big? Feb 20 2015 
J.P. Morgan Chimes In With Ratings On BioTech Stocks Jan 06 2015 
Weekly Insider Sells Highlight: REGN, HSP, TYC, AAPL Nov 30 2014 
S&P 500 Finishes Above 2,000 Aug 27 2014 
How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug Aug 20 2014 
Weekly Insider Sells Highlight: MSFT, REGN, ATVI, MAA Feb 17 2014 
Insiders Are Buying Ophthotech Oct 08 2013 

More From Other Websites
Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst... Jul 29 2015
Sanofi-Regeneron: Third Time's the Charm? Jul 29 2015
Four Reasons Gilead Can Head Higher Jul 29 2015
5 Hot Drug Stocks Top IBD's Big Cap Leaders Screen Jul 28 2015
Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal Jul 28 2015
Bah Baidu! Internet ETFs Eye Facebook, Twitter Results Jul 28 2015
Regeneron Shares Rising After Sanofi Collaboration Revealed: Good News For Shareholders? Jul 28 2015
Esperion Therapeutics: Four Reasons Bear Case Hard to Debunk Jul 28 2015
Regeneron's George Yancopoulos Becomes Pharma's First Billionaire R&D Chief Jul 28 2015
The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron... Jul 28 2015
July 28 Premarket Briefing: 10 Things You Should Know Jul 28 2015
Sanofi links with Regeneron in $2.2 bln cancer drug push Jul 28 2015
1:38 am Regeneron Pharms and Sanofi (SNY) agree to jointly advance... Jul 28 2015
Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration Jul 28 2015
Sanofi and Regeneron Launch Major New Immuno-Oncology Collaboration Jul 28 2015
Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration Jul 28 2015
Sanofi Joins Regeneron in $2.2 Billion Pact for Cancer Therapies Jul 28 2015
Why Regeneron's Approval is Bad News For Esperion Therapeutics Jul 27 2015
Have Analysts Fully Priced in Praluent to Regeneron? Jul 27 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK